Fetal hemoglobin in sickle cell anemia: Bayesian modeling of genetic associations

American Journal of Hematology

Volumn 83, Issue 3, 2008, Pages 189-195

  Sebastiani, Paola ^a   Wang, Ling ^a   Nolan, Vikki G ^b   Melista, Efthymia ^b   Ma, Qianli ^b   Baldwin, Clinton T ^b   Steinberg, Martin H ^b  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 9; BETA GLOBIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEMOGLOBIN F; HIGH MOBILITY GROUP PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; SMAD3 PROTEIN; SMAD6 PROTEIN; VASCULOTROPIN RECEPTOR 2;

ADOLESCENT; ADULT; ARTICLE; BAYES THEOREM; CHILD; CHROMOSOME 15Q; CHROMOSOME 6Q; CHROMOSOME 8Q; CHROMOSOME XP; FEMALE; GENE CLUSTER; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

ADULT; AGING; ANEMIA, SICKLE CELL; BAYES THEOREM; CHILD; CHROMOSOME MAPPING; FETAL HEMOGLOBIN; GLOBINS; HUMANS; MEMBRANE GLYCOPROTEINS; MODELS, GENETIC; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; RETICULOCYTE COUNT;

EID: 39749136185     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21048     Document Type: Article

References (41)

1. Poillon WN, et al. Sparing effect of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S at physiologic ligand saturations. Proc Natl Acad Sci USA 1993;90:5039-5043.
2. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991;325:11-16.
3. Platt OS, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330: 1639-1644.
4. Milner PF, et al. Osteonecrosis of the humeral head in sickle cell disease. Clin Orthop Relat Res 1993;283:136-143.
5. Castro O, et al. The acute chest syndrome in sickle cell disease: Incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood 1994; 84:643-649.
6. Wyszynski DF, et al. Polymorphisms near a chromosome 6q QTL area are associated with modulation of fetal hemoglobin levels in sickle cell anemia. Cell Mol Biol (Noisy-le-grand) 2004;50:23-33.
7. Garner C, et al. Haplotype mapping of a major quantitative-trait locus for fetal hemoglobin production, on chromosome 6q23. Am J Hum Genet 1998;62: 1468-1474.
8. Garner C, et al. Quantitative trait locus on chromosome 8q influences the switch from fetal to adult hemoglobin. Blood 2004;104:2184-2186.
9. Garner CP, et al. Evidence of genetic interaction between the β-globin complex and chromosome 8q in the expression of fetal hemoglobin. Am J Hum Genet 2002;70:793-799.
10. Dover GJ, et al. Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2. Blood 1992;80:816-824.
11. Stamatoyannopoulos G. Prospects for developing a molecular cure for thalassemia. Hematology 2005;10(Suppl 1):255-257.
12. Bank A. Regulation of human fetal hemoglobin: New players, new complexities. Blood 2006;107:435-143.
13. Ma Q, et al. Fetal hemoglobin in sickle cell anemia: Genetic determinants of response to hydroxyurea. Pharmacogenomics J 2007; DOI: 10.1038/sj.tpj. 6500433.
14. Palmer CR. Encyclopedia of biostatistics. BMJ 1999;318:542.
15. Figueiredo MS, Steinberg MH. Fetal hemoglobin in sickle cell anemia: Examination of phylogenetically conserved sequences within the locus control region but outside the cores of hypersensitive sites 2 and 3. Blood Cells Mol Dis 1997;23:188-200.
16. Lu ZH, Steinberg MH. Fetal hemoglobin in sickle cell anemia: Relation to regulatory sequences eis to the β-globin gene. Multicenter Study of Hydroxyurea. Blood 1996;87:1604-1611.
17. Wilkinson B, et al. TOX: An HMG box protein implicated in the regulation of thymocyte selection. Nat Immunol 2002;3:272-280.
18. Bianchi ME, Beltrame M. Flexing DNA: HMG-box proteins and their partners. Am J Hum Genet 1998;63:1573-1577.
19. Rucknagel DL, et al. Age and sex effects on hemoglobin F in sickle cell anemia. In: Stamatoyannopoulos G, Nienhuis AW, editors. Cellular and Molecular Regulation of Hemoglobin Switching. New York: Grune and Stratton; 1979. pp 107-118.
20. Mack AK, Kato GJ. Sickle cell disease and nitric oxide: A paradigm shift? Int J Biochem Cell Biol 2006;38:1237-1243.
21. Nagai R, et al. Endothelial dysfunction in the klotho mouse and downregulation of klotho gene expression in various animal models of vascular and metabolic diseases. Cell Mol Life Sci 2000;57:738-746.
22. Nakamura T, et al. Production of nitric oxide, but not prostacyclin, is reduced in klotho mice. Jpn J Pharmacol 2002;89:149-156.
23. Ikuta T, Ausenda S, Cappellini MD. Mechanism for fetal globin gene expression: Role of the soluble guanylate cyclase-cGMP-dependent protein kinase pathway. Proc Natl Acad Sci USA 2001;98:1847-1852.
24. Inoue A, et al. Negative regulation of γ-globin gene expression by cyclic AMP-dependent pathway in erythroid cells. Exp Hematol 2004;32:244-253.
25. Stamatoyannopoulos G. Molecular and cellular basis of hemoglobin switching. In: Forgret BG, Steinberg MH, Higgs DR, Nagel RL, editors. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management. Cambridge: Cambridge University Press; 2001. pp 131-145.
26. Ishibashi K, et al. Cloning and functional expression of a new aquaporin (AQP9) abundantly expressed in the peripheral leukocytes permeable to water and urea, but not to glycerol. Biochem Biophys Res Commun 1998; 244:268-274.
27. Sebastiani P, et al. Genome-wide association study using pooled DNA samples reveal new genetic modulators of HbF concentration Paper presented in National Sickle Cell Disease Program, 35th Annual Meeting 2007, Washington, DC.
28. Gaston M, Rosse WF. The cooperative study of sickle cell disease: Review of study design and objectives. Am J Pediatr Hematol Oncol 1982;4:197-201.
29. West MS, et al. Laboratory profile of sickle cell disease: A cross-sectional analysis. The Cooperative Study of Sickle Cell Disease. J Clin Epidemiol 1992; 45:893-909.
30. Steinberg MH, et al. Fetal hemoglobin in sickle cell anemia: Determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea. Blood 1997;89: 1078-1088.
31. Sebastiani P, et al. Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nat Genet 2005;37:435-440.
32. Nolan VG, et al. Association of single nucleotide polymorphisms in klotho with priapism in sickle cell anaemia. Br J Haematol 2005;128:266-272.
33. Nolan VG, et al. Sickle cell leg ulcers: Associations with haemolysis and SNPs in klotho, TEK and genes of the TGF-β/BMP pathway. Br J Haematol 2006;133:570-578.
34. Baldwin C, et al. Association of klotho, bone morphogenic protein 6, and annexin A2 polymorphisms with sickle cell osteonecrosis. Blood 2005;106: 372-375.
35. Tuan D, et al. The "beta-like-globin" gene domain in human erythroid cells. Proc Natl Acad Sci USA 1985;82:6384-6388.
36. Thein SL, et al. Detection of a major gene for heterocellular hereditary persistence of fetal hemoglobin after accounting for genetic modifiers. Am J Hum Genet 1994;54:214-228.
37. The International Hapmap Consortium. The International HapMap project. Nature 2003;426:798-796.
38. Akaike H. Information theory and an extension of the maximum likelihood principle. In Paper Presented at 2nd International Symposium on Information Theory. Kiado; 1973.
39. Smithson M, Verkuilen J. A better lemon squeezer? Maximum-likelihood regression with β-distributed dependent variables. Psychol Methods 2006;11: 54-71.
40. Balding DJ. A tutorial on statistical methods for population association studies. Nat Rev Genet 2006;7:781-791.
41. Spiegelhalter DJ, et al. Bayesian measures of model complexity and fit. J Roy Statist Soc Series B 2002;64:583-639.